Omid Farokhzad Sells 52,857 Shares of Seer, Inc. (NASDAQ:SEER) Stock

Seer, Inc. (NASDAQ:SEERGet Free Report) CEO Omid Farokhzad sold 52,857 shares of Seer stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $2.03, for a total value of $107,299.71. Following the sale, the chief executive officer now directly owns 1,436,285 shares of the company’s stock, valued at approximately $2,915,658.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Seer Stock Performance

SEER opened at $1.90 on Thursday. Seer, Inc. has a fifty-two week low of $1.46 and a fifty-two week high of $5.65. The company has a market capitalization of $121.27 million, a P/E ratio of -1.40 and a beta of 1.63. The stock has a fifty day moving average of $1.76 and a 200-day moving average of $1.90.

Seer (NASDAQ:SEERGet Free Report) last posted its earnings results on Thursday, February 29th. The company reported ($0.28) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.07. The company had revenue of $4.44 million during the quarter, compared to the consensus estimate of $4.24 million. Seer had a negative return on equity of 20.87% and a negative net margin of 517.84%. On average, equities research analysts predict that Seer, Inc. will post -1.22 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Seer

Several institutional investors and hedge funds have recently bought and sold shares of the company. Credit Suisse AG lifted its position in Seer by 8.4% during the third quarter. Credit Suisse AG now owns 23,001 shares of the company’s stock worth $178,000 after purchasing an additional 1,774 shares during the period. Bank of New York Mellon Corp lifted its position in Seer by 1.7% during the first quarter. Bank of New York Mellon Corp now owns 167,293 shares of the company’s stock worth $2,549,000 after purchasing an additional 2,734 shares during the period. American International Group Inc. lifted its position in Seer by 13.3% during the second quarter. American International Group Inc. now owns 28,221 shares of the company’s stock worth $121,000 after purchasing an additional 3,323 shares during the period. Capital Impact Advisors LLC lifted its position in Seer by 14.0% during the fourth quarter. Capital Impact Advisors LLC now owns 28,043 shares of the company’s stock worth $163,000 after purchasing an additional 3,439 shares during the period. Finally, Royal Bank of Canada lifted its position in Seer by 20.6% during the second quarter. Royal Bank of Canada now owns 23,463 shares of the company’s stock worth $101,000 after purchasing an additional 4,006 shares during the period. Institutional investors own 63.93% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley reissued an “equal weight” rating and set a $7.00 target price on shares of Seer in a report on Tuesday, March 5th.

View Our Latest Research Report on SEER

About Seer

(Get Free Report)

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.

See Also

Receive News & Ratings for Seer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seer and related companies with MarketBeat.com's FREE daily email newsletter.